PIONEERING
SOLUTIONS IN OBESITY

Lorem Ipsum is simply dummy text of the printing and typesetting industry.

PIONEERING
SOLUTIONS IN OBESITY

Lorem Ipsum is simply dummy text of the printing and typesetting industry.

Slider

About Us

Wellosophy is a US-based biotechnology company developing novel therapies that safely and effectively promote weight loss in overweight and obese patients. Our 11 cross-cultural clinical trials have consistently demonstrated highly statistically significant and clinically relevant weight loss without the need for lifestyle modification as evidenced by our CE Mark approval as a Class IIa Medical Device*. We believe that a non-invasive approach for the treatment of obesity (one of the largest health problems in the world) will have a major impact on human health.

Wellosophy is headquartered in Clearwater Beach, Florida; and was founded in 2006 by a team of physicians and researchers dedicated to finding a comprehensive solution to the global obesity pandemic.

Wellosophy is a US-based biotechnology company developing novel therapies that safely and effectively promote weight loss in overweight and obese patients. Our 11 cross-cultural clinical trials have consistently demonstrated highly statistically significant and clinically relevant weight loss without the need for lifestyle modification as evidenced by our CE Mark approval as a Class IIa Medical Device*. We believe that a non-invasive approach for the treatment of obesity (one of the largest health problems in the world) will have a major impact on human health.

Wellosophy is headquartered in Clearwater Beach, Florida; and was founded in 2006 by a team of physicians and researchers dedicated to finding a comprehensive solution to the global obesity pandemic.

Wellosophy is a US-based biotechnology company developing novel therapies that safely and effectively promote weight loss in overweight and obese patients. Our 11 cross-cultural clinical trials have consistently demonstrated highly statistically significant and clinically relevant weight loss without the need for lifestyle modification as evidenced by our CE Mark approval as a Class IIa Medical Device*. We believe that a non-invasive approach for the treatment of obesity (one of the largest health problems in the world) will have a major impact on human health.

Wellosophy is headquartered in Clearwater Beach, Florida; and was founded in 2006 by a team of physicians and researchers dedicated to finding a comprehensive solution to the global obesity pandemic.

Our Market

Global Obesity Pandemic

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.

Watch Our Video

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.

The standard chunk of Lorem Ipsum used since the 1500s is reproduced below for those interested. Sections 1.10.32 and 1.10.33 from "de Finibus Bonorum et Malorum" by Cicero are also reproduced in their exact original form, accompanied by English versions from the 1914 translation by H. Rackham.

Our Technology

 

 

HydroSlim

HydroSlim is a proprietary, first-to-market, Class IIa medical device comprised of an ingestible, water-swellable, superabsorbent hydrogel called SWELL™ approved* for the treatment of weight loss in otherwise healthy overweight and obese adults with BMI ranging from 25-41 kg/m2HydroSlim is a proprietary, first-to-market, Class IIa medical device comprised of an ingestible, water-swellable, superabsorbent hydrogel called SWELL™ approved* for the treatment of weight loss in otherwise healthy overweight and obese adults with BMI ranging from 25-41 kg/m2.

 

Learn More

Technology

SWELL is a patented, ultra-pure, pharmaceutical-grade, superabsorbent hydrogel designed specifically for water-swellable expansion within the gastric environment. SWELL is comprised of polyacrylic acid sidechains crosslinked with low molecular weight PEG to form an ultra-porous interpenetrating polymer network. The technology is delivered in two-piece vegetarian capsules…

Learn More

Mechanism of Action

HydroSlim is a proprietary, first-to-market, Class IIa medical device comprised of an ingestible, water-swellable, superabsorbent hydrogel called SWELL™ approved* for the treatment of weight loss in otherwise healthy overweight and obese adults with BMI ranging from 25-41 kg/m2HydroSlim is a proprietary, first-to-market, Class IIa medical device comprised of an ingestible, water-swellable, superabsorbent hydrogel called SWELL™ approved* for the treatment of weight loss in otherwise healthy overweight and obese adults with BMI ranging from 25-41 kg/m2.

Learn More

Clinical Results

HydroSlim has been evaluated in 11 clinical trials, culminating in the SHORT-1 Pivotal Trial (randomized prospective, placebo-controlled trial; n=126). Remarkable correlation (c=94.6%) among all of the studies has demonstrated an average weight loss of 8 lbs. per month with lifestyle changes.

Learn More

Regulatory Approvals 


European Union CE Mark Class IIa


Chile Medical Device Class IIa


Russia Medical Device Class IIa

Patents


USA


Japan


Russia


European Union PCT


China


Others Pending

Competition


HydroSlim Less than 2% Very mild Belching Gas


OTC and RX Drugs Anxiety, Depression, Constipation, Insomnia, Hypertension, Tachycardia, Dizziness, Diarrhea, High Abuse Potential, Stroke, Heart Attack


Devices Bleeding, Infection, Nausea, Device Failure, Pulmonary Embolism, Death


Gastric Bypass Bleeding, Infection, Depression, Blood Clots , Mal absorption, Severe Diarrhea, Death

Press Release

Wellosophy® Corporation Announces Receipt of its CE Mark

Clearwater, FL, February 10, 2017: Wellosophy® Corporation is a privately-held, US-based biotechnology company developing novel therapies that safely promote weight loss in overweight and obese patients. The Company, in cooperation with Eladiet S.A., its European partner (Barcelona, Spain: a CE-certified, cGMP maker of Nutraceuticals and Medical Devices), today announced...

Learn More

Contact Us

PO Box 5598 Clearwater, FL 33758-5598